CBNS researchers have a range of collaborations with commercial organisations. These relationships are typically led by one of our Chief Investigators and link with Australian and international bioscience and biotech experts. The collaborations provide an opportunity for bio-nano research to be translated into product development and, ultimately, application and use.
Current collaborations are detailed below. For more information please contact the CBNS researcher listed.
We also have significant health and medical sector collaborations.
CBNS always seeks new collaborations. If you have ideas for the next step for any of our research, please contact any of our researchers or the CBNS Director or Centre Manager.
The CBNS IP and commercialisation policy provides additional information but please contact the CBNS Centre Manager if you have any questions.
| Collaborating Company | Main Contact | Project |
|---|---|---|
| Aegros International | Professor Kris Thurecht | Smart affinity membranes for advanced manufacturing of high-value therapeutic proteins |
| Affinity Bio | Professor Stephen Kent | Generation of novel anti-HIV antibodies |
| AgaMatrix Inc. | Professor Maria Kavallaris Professor Justin Gooding |
Development of a new dispersible electrode concept for detecting low levels of microRNA in blood as a biomarker of disease |
| Anteo Diagnostics | Professor Andrew Whittaker | Protein attachment chemistry for devices |
| ANU | Professor Stephen Kent | Studying novel HIV vaccines that induce highly potent T cell immunity |
| AstraZeneca | Professor Kris Thurecht | Joint PhD studentship |
| bioCSL | Professor Stephen Kent | Improved influenza vaccines |
| Bionomics Ltd. (funded by a Future Industries Accelerator grant) |
Professor Benjamin Thierry | Clinical blood biomarker and target engagement analysis for bionomics BNC101Phase I clinical trial |
| Capsugel | Professor Chris Porter | Ionic liquid technology for drug delivery |
| Ceramisphere Ltd. (funded by an ARC Linkage grant) |
Professor Benjamin Thierry Professor Clive Prestidge |
Development of an in vitro model of the intestinal epithelium to optimise oral nano-vaccine |
| Clarity Pharmaceuticals | Professor Kris Thurecht | Biodistribution and targeting of biomolecules |
| Dow Chemical Company | Professor Andrew Whittaker | Photo-responsive hydrogels (ARC DP funded) |
| Ferronova Ltd. (funded by TechinSA) |
Professor Benjamin Thierry | Improving Head and Neck Cancer staging with nanoparticles |
| GlaxoSmithKline Doherty Institute |
Professor Stephen Kent | Novel drugs to inhibit HIV entering the latent phase |
| Halozyme Therapeutics | Professor Chris Porter | Perturbation of the extracellular architecture to promote the absorption and lymphatic transport of biological macromolecules |
| Inter-K | Professor Kris Thurecht | Biodistribution, pharmacokinetics and efficacy of peptide therapeutics |
| Inventia Life Sciences | Professor Justin Gooding Professor Maria Kavallaris Professor Tom Davis |
Developing bioinks and 3D printers for the 3D printing of cells |
| Luminosity Innovations | Professor Justin Gooding | Sun exposure technology |
| Merck | Professor Stephen Kent | Novel delivery mechanisms to reduce harmful inflammation in infectious diseases such as HIV |
| Minomic | Professor Kris Thurecht | Biodistribution and targeting of antibodies towards prostate cancer |
| Minomic | Professor Kris Thurecht | Developing biospecific antibodies for targeted therapeutics |
| Murdoch University WaterNSW Seqwater |
Professor Benjamin Thierry | Development and validation of rapid detection and viability assays for Cryptosporidium, Norovirus, and Adenovirus and using a novel gut-on-chip |
| Nano-Nouvelle Pty Ltd | Professor Nico Voelcker | Development of electrochemical biosensors for cardiac biomarkers |
| National AIDS Research Institute International AIDS Vaccine Initiative |
Professor Stephen Kent | Developing improved measurements of HIV immunity across different population groups |
| NVIDIA | Associate Professor John McGhee | RT Cell – Realtime previewing of 3D molecular models in Maya and Vray |
| PolyActiva | Professor Tom Davis Dr Michael Whittaker |
A study of the interrelationships between drug release and polymer biodegradation of novel drug-polymer conjugates (DPCs) |
| PregTech Pty Ltd | Professor Nico Voelcker | Co-development of biosensors for veterinary applications |
| PureTech Health | Professor Chris Porter | Targeting the lymphatic system using glyceride-mimetic prodrugs |
| RHS Ltd and Repromed | Professor Benjamin Thierry | Development of a novel non-invasive prenatal testing technology based on circulating fetal cells |
| SA Water | Professor Nico Voelcker | Development of biosensors for water quality |
| Sanofi-Pasteur | Professor Stephen Kent Dr Adam Wheatley |
Antibodies for broad protection against influenza B |
| StarPharma | Professor Kris Thurecht | Imaging the distribution of dendritic nanomedicines |
| Starpharma | Professor Chris Porter Dr Angus Johnston |
Novel targeted delivery systems |
| Starpharma | Professor Chris Porter | Dendrimers for advanced drug delivery |
| Telex Pharmaceuticals | Professor Kris Thurecht | Biodistribution, pharmacokinetics and efficacy of therapeutic antibodies |
| Tour de Cure Pioneering Cancer Research | Professor Maria Kavallaris Professor Nico Voelcker |
Precision nanomedicine for the treatment of neuroblastoma |
